Murray Leaving Innovation Consortium, But Optimistic About Group's Future
Executive Summary
Bill Murray is stepping down as CEO of the Medical Device Innovation Consortium on Feb. 2, but he will be helping the group during the leadership transition period, and says he's excited about several long-term projects, including one designed to help better understand the evidence requirements sponsors should consider in pre-market trials to satisfy Medicare requirements. Murray spoke to Medtech Insight; read about it and listen to the podcast interview.